10 Doctors Debunk Breast Cancer Myths, Explain Risk Factors and Prevention

In 2024, breast cancer claimed roughly 694,000 lives worldwide and appeared in 2.4 million new patients, making it the most frequently diagnosed cancer among women across 164 of 186 countries. On World Breast Cancer Day, ten Indian oncologists gathered to address a gap that persists even as screening technology advances: the myths that circulate about what causes breast cancer, and the hard limits of the tools we use to find it.

One of the most consequential facts emerged early in the conversation. Mammograms, the standard screening tool, miss approximately one in eight breast cancers that are actually present at the time of the scan. The reason is partly anatomical. Women with dense breast tissue face a double burden—their tissue itself carries higher cancer risk, and the density makes mammograms less effective at detecting tumors. Dr. Darshana Rane, a medical oncologist, explained that cancers can develop between screenings or slip past detection entirely, particularly in women with dense breasts. Ultrasound can help assess lumps, while MRI may be deployed for high-risk screening or deeper investigation. But supplemental imaging brings its own problem: false positives that can trigger unnecessary anxiety and follow-up procedures. The practical consequence is that a normal mammogram does not guarantee the absence of cancer. Persistent lumps, nipple discharge, nipple inversion, or skin changes warrant clinical evaluation even after a clean scan.

The distinction between screening and diagnostic mammograms matters. Screening mammograms look for cancer in women without symptoms; diagnostic imaging investigates symptoms or abnormal findings that have already surfaced. Most breast lumps turn out to be benign—cysts and fibroadenomas are common—but a new, persistent lump cannot be reliably identified as benign by touch alone. Every new lump, whether painful or painless, soft or hard, needs clinical assessment and, if necessary, imaging or biopsy. Breast injuries can cause bruising or fat necrosis, producing a lump, or they can draw attention to a pre-existing lump that was already there. But trauma itself does not cause breast cancer. This distinction matters because it separates cause from coincidence.

Beyond lumps, other symptoms demand attention. Persistent redness, swelling, warmth, orange-peel-like skin texture, dimpling, or nipple inversion warrant evaluation. Inflammatory breast cancer may progress quickly without a distinct lump, and persistent nipple rashes, bleeding, ulceration, or unexplained armpit swelling also need assessment. Itching, redness, and rashes often result from benign conditions, but they can sometimes signal inflammatory breast cancer or Paget disease. The doctors emphasized that early breast cancer may cause neither pain nor a noticeable lump; mammograms can detect microcalcifications or small tumors before they can be felt, which is why younger women with strong family history, BRCA1 or BRCA2 mutations, or previous chest radiation at a young age may need earlier screening.

Family history and genetic risk reshape screening strategy. Women with a strong family history of breast or ovarian cancer, inherited mutations, or previous chest radiation at a young age may need earlier or more intensive screening, including MRI. Genetic counseling becomes relevant when several relatives have had breast or ovarian cancer, particularly at younger ages. Screening recommendations vary, and there is no single schedule suitable for every woman. The doctors advised women whose mother, sister, or daughter has had breast cancer to discuss their individual risk with a physician.

Lifestyle factors carry measurable weight. Experts recommend maintaining a healthy weight, exercising regularly, eating a balanced diet, avoiding smoking, and limiting or avoiding alcohol. Alcohol is an established breast cancer risk factor. These measures cannot eliminate cancer risk, but they can reduce it. Hormonal contraceptives are associated with a small increase in breast cancer risk. Combined menopausal hormone therapy containing estrogen and progestogen is also associated with increased risk, particularly with longer use. The doctors cautioned against stopping medication on one's own; these treatments have important benefits, and the risks and alternatives warrant discussion with a physician.

A constellation of myths persists despite the evidence. Breast injuries and squeezing do not cause cancer. Ordinary deodorants and antiperspirants have not been shown to cause it. Massage or lymphatic drainage cannot treat or dissolve a breast lump. There is no convincing evidence that tight or underwired bras increase breast cancer risk or that bras block lymphatic drainage and cause cancer. Mammogram compression and breast biopsies do not spread cancer. No single food, supplement, or product guarantees breast cancer prevention. The doctors warned against relying on home remedies, massage, or detox products to prevent or treat cancer. The clarity here is important: these are not matters of opinion or competing theories. They are settled by evidence.

The practical takeaway is that breast cancer screening and prevention require both vigilance and precision. Vigilance means knowing what changes warrant evaluation—new lumps, nipple discharge, skin dimpling, persistent rashes. Precision means understanding that screening tools have limits, that family history and genetic status reshape risk, and that lifestyle choices matter but do not guarantee protection. For women with elevated risk, earlier and more intensive screening is warranted. For all women, persistent or rapidly worsening changes deserve prompt medical evaluation.